MAGNET Ingestion in Children (MAGNETIC)

Magnet Ingestion in Children: a Prospective Surveillance Study

One year national observational surveillance study of children who ingest a magnetic foreign body

Study Overview

Status

Completed

Conditions

Detailed Description

The study aims to understand the incidence, management and outcomes of children who ingest a magnetic foreign body.

Study Type

Observational

Enrollment (Actual)

366

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Southampton, United Kingdom, SO16 6YD
        • Southampton Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 15 years (Child)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Definite magnetic foreign body ingestion in children <16yrs

Description

Inclusion Criteria:

  • Magnetic foreign body ingestion
  • 16 years of age or less

Exclusion Criteria:

  • Non ingested foreign body

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Incidence of MAGNETIC Foreign Body Ingestion
Time Frame: Over 1 year from May 1st 2022
Over 1 year from May 1st 2022

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Investigations and management of magnetic foreign body ingestion
Time Frame: Up to 28 days following ingestion
What investigations and treatments these children had
Up to 28 days following ingestion
Outcomes of magnetic foreign body ingestion
Time Frame: Up to 28 days following ingestion
What the outcomes were
Up to 28 days following ingestion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2022

Primary Completion (Actual)

April 30, 2023

Study Completion (Actual)

December 31, 2023

Study Registration Dates

First Submitted

May 4, 2022

First Submitted That Met QC Criteria

May 10, 2022

First Posted (Actual)

May 17, 2022

Study Record Updates

Last Update Posted (Actual)

April 17, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHI1116

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Foreign Bodies

Subscribe